Tag: FDA

FDA orders manufacturers to stop selling gynecologic mesh

Editor's Note The Food and Drug Administration (FDA) on April 16 announced that it had ordered manufacturers of surgical mesh products indicated for transvaginal repair of pelvic organ prolapse to stop selling and distributing their products in the US, immediately. The FDA has determined that manufacturers, Boston Scientific and Coloplast,…

Read More

By: Judy Mathias
April 22, 2019
Share

FDA continues efforts to assess duodenoscope contamination risk

Editor's Note The Food & Drug Administration (FDA) on April 12 announced that it is taking steps to implement additional regulatory actions, including consulting with federal health experts, on how to reduce the risks of contamination and infections linked to duodenoscopes. The agency is also collaborating with manufacturers of disposable…

Read More

By: Judy Mathias
April 18, 2019
Share

FDA issues statement on trach tube shortages

Editor's Note The Food & Drug Administration on April 12 issued a statement about the agency’s efforts to mitigate the shortage of Smiths Medical’s Bivona tracheostomy tubes, especially the pediatric tubes. The shortage is a result of the closure of a large ethylene oxide sterilization facility in Willowbrook, Illinois, and there…

Read More

By: Judy Mathias
April 17, 2019
Share

FDA: Class I recall of Brainlab Spine & Trauma 3D Navigation Software

Editor's Note The Food & Drug Administration (FDA) on April 15 identified the recall of Brainlab's Spine & Trauma 3D Navigation Software as Class I, the most serious. The Software is being recalled because of the potential for incorrect information to display during surgery, which may prevent the surgeon from…

Read More

By: Judy Mathias
April 16, 2019
Share

FDA to require label changes on how to safely decrease opioids in physically dependent patients

Editor's Note The Food & Drug Administration (FDA) on April 9 issued a Drug Safety Announcement saying it has received reports of serious harm in patients who are physically dependent on opioid pain medications and suddenly have them discontinued or rapidly decreased. Because of these reports, the FDA is requiring…

Read More

By: Judy Mathias
April 11, 2019
Share

FDA issues statement on review framework for AI-based devices

Editor's Note The Food & Drug Administration (FDA) on April 2 issued a statement announcing steps toward a new, tailored review framework for artificial intelligence (AI)-based medical devices. AI and machine learning have the potential to transform the delivery of healthcare, with earlier disease detection, more accurate diagnoses, more targeted…

Read More

By: Judy Mathias
April 3, 2019
Share

FDA addresses potential medical device, product shortages amid shutdown of sterilization facility

Editor's Note The Food & Drug Administration on March 26 said it will take steps to address potential medical product and device shortages because of the recent closure of a large contract sterilization facility, Sterigenics (Willowbrook, Illinois). Earlier this year, the Illinois Environmental Protection Agency issued an order to stop…

Read More

By: Judy Mathias
March 27, 2019
Share

FDA issues Safety Communication on cybersecurity vulnerabilities in Medtronic cardiac devices

Editor's Note The Food & Drug Administration on March 21 issued a Safety Communication on cybersecurity vulnerabilities identified in wireless telemetry technology used for communication between Medtronic’s implantable cardiac devices, clinic programmers, and home monitors. Medtronic (Dublin, Ireland) is working on updates to address the vulnerabilities and recommends that healthcare…

Read More

By: Judy Mathias
March 25, 2019
Share

FDA issues warning letters to two breast implant manufacturers

Editor's Note The Food & Drug Administration (FDA) on March 19 issued warning letters to two breast implant manufacturers (Mentor Worldwide LLC of Irvine, California, and Sientra, Inc of Santa Barbara, California) for failing to comply with post-approval study requirements. All manufacturers of approved silicone gel-filled implants are required to…

Read More

By: Judy Mathias
March 21, 2019
Share

FDA: Class I recall of Cook Medical’s Transseptal Needle

Editor's Note The Food and Drug Administration on March 18 identified the recall by Cook Medical Inc (Bloomington, Indiana) of one lot of its Transseptal Needles as Class I, the most serious. The recall was initiated because of a manufacturing error that resulted in some needle tips missing the back…

Read More

By: Judy Mathias
March 19, 2019
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat